Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting [Corrigendum]

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting [Corrigendum]

Senbel E, Tropé S, Herman-Demars H, et al. Patient Prefer Adherence. 2021;15:751–760. Page 751, Abstract, Results section, the text “Switch to SC route increased the proportion of patients with remission or LDA from 22.8% to 52.9% and increased quality of life even in...

Full description

Bibliographic Details
Main Authors: Senbel E, Tropé S, Herman-Demars H, Zinovieva E, Courbeyrette A, Clerson P, Fardini Y, Flipo RM
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:Patient Preference and Adherence
Subjects:
rheumatoid arthritis
methotrexate
oral
subcutaneous
compliance
switch
Online Access:https://www.dovepress.com/corrigendum-benefits-of-switch-from-oral-to-subcutaneous-route-on-adhe-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/corrigendum-benefits-of-switch-from-oral-to-subcutaneous-route-on-adhe-peer-reviewed-fulltext-article-PPA

Similar Items